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background:  The maximal left atrium (LA) size is a significant predictor of future atrial fibrillation (AF) however the minimal LA size, which 
better reflects LA function, may be superior in predicting future AF in the general population.
Methods:  In a large general population study, 2,200 participants underwent a health examination with echocardiography. The maximal LA 
volume (LAV max) and the minimal LA volume (LAV min) were measured. Participants with known atrial fibrillation were excluded (n=48).
results:  During follow-up (median 11.0 years), 184 (9.4%) participants were diagnosed with AF. Participants who were diagnosed with 
AF during follow-up had both a significant larger LAV max and LAV min compared to participants without AF (LAV max: 23 mL/m2 vs. 19 
mL/m2, p<0.0001; LAV min: 13 mL/m2 vs. 9 mL/m2, p<0.0001). The risk of AF increased significantly with increasing LAV max and LAV 
min, with a 10 % higher and 14 % higher risk per 1 mL/m2 increase, respectively (LAV max: HR 1.10 (CI 1.08-1.12), p<0.001; LAV min: 
1.14 (CI 1.08-1.12), p<0.001). In direct comparison, LAV min was a significantly stronger predictor of future AF than LAV max determined 
by a significantly higher Harrell’s C-statistics (0.70 vs. 0.65, p=0.001). After multivariable adjustment for all clinical and echocardiographic 
(ejection fraction (LVEF), deceleration time, left ventricular mass index, E/e’, left ventricular end-diastolic dimension) parameters, both the 
LAV max and the LAV min remained independent predictors of future AF (LAV max: HR 1.03 (CI 1.00-1.06), p=0.026; LAV min: 1.05 (CI 
1.01-1.09), p=0.020). However, only LAV min (not LAV max) provided incremental prognostic information when added to a model already 
including significant predictors of AF (age, sex, BMI, eGFR, heart rate, systolic and diastolic BP, hypertension, cholesterol, diabetes, 
smoking status, ischemic heart disease, ischemic stroke, COPD and LVEF), determined by a significant increase in the Harrell’s C-statistics 
(0.85 vs 0. 84, p=0.012
Conclusion:  The LAV min is not only an independent predictor of AF in the general population, but provides incremental prognostic 
information to well known risk factors for AF.
